![Jude Onyia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jude Onyia
Directeur Technique/Scientifique/R&D chez
NEUROCRINE BIOSCIENCES, INC.
Fortune : 3 M $ au 30/09/2026
Profil
Dr. Jude Onyia is a Chief Scientific Officer at Neurocrine Biosciences, Inc. He is on the Board of Directors at Voyager Therapeutics, Inc. Dr. Onyia was previously employed as a Chief Scientific Officer by Capsida Biotherapeutics, Inc. and a Vice President-Biotechnology Discovery Research by Eli Lilly & Co. He received his undergraduate degree from Suny College of Environmental Science & Forestry, a doctorate degree from SUNY Upstate Medical University and a doctorate degree from State University of New York at Downstate Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/09/2026 | 22 647 ( 0,02 % ) | 3 M $ | 30/09/2026 | |
| 09/06/2026 | 2 910 ( 0 % ) | 7 799 $ | 30/09/2026 |
Postes actifs de Jude Onyia
| Sociétés | Poste | Début |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 30/11/2021 |
| VOYAGER THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/02/2023 |
Anciens postes connus de Jude Onyia
| Sociétés | Poste | Fin |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Directeur Technique/Scientifique/R&D | 01/11/2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/06/2021 |
Formation de Jude Onyia
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
SUNY College of Environmental Science
 SUNY College of Environmental Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SUNY Upstate Medical University
 SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Downstate Medical Center
 State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
